FBC
HCAT icon

Fairfield, Bush & Co’s Health Catalyst HCAT Stock Holding History

Fairfield, Bush & Co’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$4.63K – 256
2023
Q4 		$4.63K Buy
+500
New +$4.09K ﹤0.01% 355
2023
Q3 		– Sell
-600
Closed -$7.5K – 266
2023
Q2 		$7.5K Buy
+600
New +$7.15K ﹤0.01% 347
2022
Q3 		– Sell
-975
Closed -$14K – 253
2022
Q2 		$14K Buy
+975
New +$16.6K 0.01% 279

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fairfield, Bush & Co's HCAT Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 500 shares — an estimated $4.63K sold.

Fairfield, Bush & Co first reported a position in HCAT in Q2 2022 and held it in 3 quarters. The position peaked at $14K in Q2 2022. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 500 Health Catalyst shares in Q1 2024, an estimated $4.63K.
  • Fairfield, Bush & Co first reported a position in Health Catalyst in Q2 2022 and held it in 3 quarters.
  • Fairfield, Bush & Co's Health Catalyst position peaked at $14K in Q2 2022.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.